Prognostic value of hypoalbuminemia at diagnosis in de novo non-M3 acute myeloid leukemia

References

• Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–2107.
   PubMed Web of Science ®Google Scholar
• Hassan S, Smith M. Acute myeloid leukaemia. Hematology. 2014;19(8):493–494.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• O'Donnell MR, Tallman MS, Abboud CN, et al. Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(7):926–957.
   PubMed Web of Science ®Google Scholar
• Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7(S3):193–199.
   PubMed Web of Science ®Google Scholar
• Dupire S, Wemeau M, Debarri H, et al. Prognostic value of PINI index in patients with multiple myeloma. Eur J Haematol. 2012;88(4):306–313.
   PubMed Web of Science ®Google Scholar
• Tandon S, Moulik NR, Kumar A, et al. Effect of pre-treatment nutritional status, folate and vitamin B12 levels on induction chemotherapy in children with acute lymphoblastic leukemia. Indian Pediatr. 2015;52(5):385–389.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Go S-I, Seo J, et al. Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2018;71:100–105.
   PubMed Web of Science ®Google Scholar
• Komrokji RS, Corrales-Yepez M, Kharfan-Dabaja MA, et al. Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes. Am J Hematol. 2012;87(11):1006–1009.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Storer BE, Fathi AT, et al. Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality. JAMA Oncol. 2017;3(12):1675–1682.
   PubMed Web of Science ®Google Scholar
• Filliatre-Clement L, Broseus J, Muller M, et al. Serum albumin or body mass index: which prognostic factor for survival in patients with acute myeloblastic leukaemia? Hematol Oncol. 2018;37(1):80–84.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-Operative Group. Br J Haematol. 1976;33(4):451–458.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Fey MF, Buske C. Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl. 6):vi138–vi143.
   PubMedGoogle Scholar
• Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453–474.
   PubMed Web of Science ®Google Scholar
• Wattad M, Weber D, Döhner K, et al. Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure. Leukemia. 2017;31(6):1306–1313.
   PubMed Web of Science ®Google Scholar
• An International System for Human Cytogenetic Nomenclature (1985) ISCN 1985. Report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig Artic Ser. 1985;21(1):1–117.
   Google Scholar
• Schlenk RF, Frech P, Weber D, et al. Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia. Leukemia. 2017;31(5):1217–1220.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
   PubMed Web of Science ®Google Scholar
• Lai C-C, You J-F, Yeh C-Y, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011;26(4):473–481.
   PubMed Web of Science ®Google Scholar
• Lohsiriwat V, Lohsiriwat D, Boonnuch W, et al. Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol. 2008;14(8):1248–1251.
   PubMed Web of Science ®Google Scholar
• Sarkiss CA, Hersh EH, Ladner TR, et al. Risk factors for thirty-day morbidity and mortality in extradural lumbar spine tumor resection. World Neurosurg. 2018;114:e1101–e1106.
   PubMed Web of Science ®Google Scholar
• Kubo N, Sakurai K, Tamura T, et al. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer. Esophagus. 2018;16(2):147–154.
   PubMed Web of Science ®Google Scholar
• Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606.
   PubMed Web of Science ®Google Scholar
• Zeller B, Glosli H, Forestier E, et al. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10(9)/l. The NOPHO experience 1984–2014. Br J Haematol. 2017;178(3):448–456.
   PubMed Web of Science ®Google Scholar
• Wong GC. Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis. Ann Hematol. 2015;94(12):2067–2068.
   PubMed Web of Science ®Google Scholar
• Marbello L, Ricci F, Nosari AM, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res. 2008;32(8):1221–1227.
   PubMed Web of Science ®Google Scholar
• Boddu PC, Kantarjian HM, Ravandi F, et al. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach. Cancer. 2017;123(16):3050–3060.
   PubMed Web of Science ®Google Scholar
• Binder S, Luciano M, Horejs-Hoeck J. The cytokine network in acute myeloid leukemia (AML): a focus on pro- and anti-inflammatory mediators. Cytokine Growth Factor Rev. 2018;43:8–15.
   PubMed Web of Science ®Google Scholar
• Chen T, Zhang J, Zeng H, et al. The impact of inflammation and cytokine expression of PM2.5 in AML. Oncol Lett. 2018;16(2):2732–2740.
   PubMed Web of Science ®Google Scholar
• Bacha S, Mejdoub El Fehri S, Habibech S, et al. Impact of malnutrition in advanced non-small cell lung cancer. Tunis Med. 2018;96(1):59–63.
   PubMedGoogle Scholar
• Kirov KM, Xu HP, Crenn P, et al. Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience. Eur J Surg Oncol. 2018;45(2):261–267.
   PubMed Web of Science ®Google Scholar
• Yokota T, Ando N, Igaki H, et al. Prognostic factors in patients receiving neoadjuvant 5-fluorouracil plus cisplatin for advanced esophageal cancer (JCOG9907). Oncology. 2015;89(3):143–151.
   PubMed Web of Science ®Google Scholar
• Wiczer T, Dotson E, Tuten A, et al. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. J Oncol Pharm Pract. 2016;22(3):430–436.
   PubMed Web of Science ®Google Scholar
• Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484–492.
   PubMed Web of Science ®Google Scholar
• Megias-Vericat JE, Montesinos P, Herrero MJ, et al. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. Leuk Lymphoma. 2017;58(12):2880–2894.
   PubMed Web of Science ®Google Scholar